neurokinin 3 receptor antagonist

Neurokinin-3 Receptor Antagonists: A Novel Approach to Treating Menopausal Vasomotor Symptoms

A New Drug Application was submitted to the FDA for a novel, nonhormonal dual neurokinin-1 and neurokinin-3 receptor antagonist for the treatment of menopause-related vasomotor symptoms.

By Ruta Nonacs, MD PhD|2025-06-26T08:06:12-04:00August 8th, 2024|Women's Mental Health|Comments Off

Neurokinin Receptor Antagonists for the Treatment of Menopausal Symptoms

About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase. For most, the symptoms are manageable, but for a sizeable subset of midlife [...]

By MGH Center for Women's Mental Health|2020-02-29T11:39:05-04:00October 15th, 2019|Menopausal Symptoms|Comments Off